Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DVUC | ISIN: NZAFTE0001S4 | Ticker-Symbol:
Branche
Versorger
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
AFT PHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
AFT PHARMACEUTICALS LIMITED 5-Tage-Chart

Aktuelle News zur AFT PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiAFT PHARMACEUTICALS LIMITED: AFT reports record sales and invests for growth1
DiAFT PHARMACEUTICALS LIMITED: FY25 Interim Report-
DiAFT PHARMACEUTICALS LIMITED: FY25 Interim Presentation-
DiAFT PHARMACEUTICALS LIMITED: FY25 Interim release-
DiAFT PHARMACEUTICALS LIMITED: FY25 Interim NZX App2-
12.11.AFT PHARMACEUTICALS LIMITED: AFT appoints Allison Yorston as independent director-
07.11.AFT PHARMACEUTICALS LIMITED: SPH Notice - Accident Compensation Corporation (ACC)1
07.11.AFT PHARMACEUTICALS LIMITED: Change in substantial holding1
AFT PHARMACEUTICALS Aktie jetzt für 0€ handeln
04.11.AFT Pharmaceuticals - H125 profitability weighed down by one-offs185AFT Pharmaceuticals has released a trading update ahead of its H125 results, expecting to report a c NZ$2m operating loss for the period ending September 2024, driven by one-off factors affecting the...
► Artikel lesen
31.10.AFT PHARMACEUTICALS LIMITED: AFT trading update-
20.10.AFT PHARMACEUTICALS LIMITED: AFT enters late-stage R&D agreement for a novel injectable-
20.10.AFT PHARMACEUTICALS LIMITED: AFT enters late-stage R&D agreement for a novel injectable-
11.10.AFT PHARMACEUTICALS LIMITED: Interim results announcement Thurs Nov 21 20242
11.10.AFT PHARMACEUTICALS LIMITED: Interim results to be announced on Nov 21 20241
30.09.AFT Pharmaceuticals - Maxigesic IV reaches the Chinese shores167AFT Pharmaceuticals has taken another major step in extending its international footprint, with the signing of an exclusive license agreement for Maxigesic IV in China, the second-largest pharma market...
► Artikel lesen
30.09.AFT PHARMACEUTICALS LIMITED: China and USA updates1
29.09.AFT PHARMACEUTICALS LIMITED: AFT Licenses Maxigesic IV in China and USA update-
09.08.AFT Pharmaceuticals - Hikma partnership expands to include Combogesic300AFT Pharmaceuticals has expanded its licensing partnership with Hikma in the US to include distribution of the recently launched Combogesic tablets (Maxigesic Rapid). We view this as a logical step...
► Artikel lesen
08.08.AFT PHARMACEUTICALS LIMITED: AFT adds COMBOGESIC Tablets to Hikma Agreement in US-
02.08.AFT PHARMACEUTICALS LIMITED: results of 2024 ASM-
Seite:  Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1